We previously demonstrated that angiotensin II is able to induce alterations in human AF-MSCs at various levels (genetic, metabolic, and epigenetic) leading to the initiation of cardiomyogenic differentiation [9]. This evidence concerns the gene AGT and atrial fibrillation.